COMMUNIQUÉS West-GlobeNewswire

New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting
03/11/2025
REDWOOD CITY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that results from its [...]
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
03/11/2025
CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a [...]
Solana Company (NASDAQ: HSDT) Releases Investor Update
03/11/2025
NEWTOWN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced the [...]
Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T Cell Therapies at the 67th American Society of Hematology Annual Meeting
03/11/2025
SOMERVILLE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced three presentations of new [...]
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
03/11/2025
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
Almafit Announces Strategic Partnership with Renowned Pilates Expert Lisa Hubbard
03/11/2025
Collaboration empowers midlife Pilates enthusiasts with innovative equipment and expert guidance. Duluth, Georgia, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Almafit , a developer of premium Pilates reformers, today announced a [...]
Baylor Genetics Applauds Medi-Cal's Decision to Cover Whole Genome Sequencing
03/11/2025
Decision brings total number of Medicaid programs offering WGS coverage to 30 states and Puerto Rico HOUSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading clinical diagnostic laboratory at the forefront [...]
Scilex Holding Company Announces the Sponsorship of Dream Bowl 2026 and Set a Record Date of November 14, 2025 for Its Shareholders to Receive Dream Bowl 2026 Meme Coin Distributed by DataVault AI
03/11/2025
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Mira Aesthetic Cosmetic Surgery Center Supports Local Athletics with Charitable Donation to Corona del Mar High School
03/11/2025
NEWPORT BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Mira Aesthetic Cosmetic Surgery Center , led by board-certified surgeon Dr. Sid Mirrafatti, today announced a charitable contribution to Corona del Mar High [...]
Syncx Announces Strategic Partnership with Fetch Data and Assist ATS, Creating the First Fully Connected Healthcare MSP, VMS, Sourcing and Staffing Operating System
03/11/2025
ATLANTA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Syncx, the healthcare workforce-management platform redefining how health systems manage locum tenens, float pools, contingent and permanent labor, today announced a three-way [...]
Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
03/11/2025
At 24 months, the target lesion primary patency (TLPP) 1 was 41.7% At 24 months, the access circuit primary patency (ACPP) 2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. ( [...]
Global Congress of Polish Medical Communities “Save a Life” 2025 – A Worldwide Mission to Advance Life-Saving Expertise
03/11/2025
International collaboration, medical excellence, and integration of Polish medical professionals worldwide WARSAW, Poland, Nov. 03, 2025 (GLOBE NEWSWIRE) -- On 21–22 November 2025 , the Warsaw Medical University ( [...]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
03/11/2025
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that Markus [...]
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025
03/11/2025
Company to Host Conference Call at 8:30am ET REHOVOT, Israel and HOBOKEN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a [...]
Multiple Myeloma Research Foundation Joins Forces with Patients and Caregivers for Road to Victories Fundraiser
03/11/2025
MMRF’s four-day Road to Victories ride will raise awareness and funds to accelerate a cure for every patient with multiple myeloma NORWALK, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Multiple Myeloma Research [...]
Jade Biosciences to Participate in Upcoming Conferences
03/11/2025
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune [...]
Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment
03/11/2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and Ibogaine therapies for unmet [...]
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
03/11/2025
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
03/11/2025
—Q3 2025 ORLADEYO net revenue of $159.1 million (+37 percent y-o-y)— —Q3 2025 operating profit of $29.6 million (+285 percent y-o-y); non-GAAP operating profit of $51.7 million (+107 percent y-o-y); continued [...]

Pages